1,25-Dihydroxyvitamin D3 and adenosine 3',5'-monophosphate synergistically promote differentiation of a monocytic cell line.
J E
JE
Rubin
D E
DE
Chenoweth
B D
BD
Catherwood
D015056:1-Methyl-3-isobutylxanthine / Q000494:pharmacology; D003994:Bucladesine / Q000494:pharmacology; D002117:Calcitriol / Q000494:pharmacology*; D002454:Cell Differentiation / Q000187:drug effects; D002460:Cell Line; D005576:Colforsin / Q000494:pharmacology; D003182:Complement C5 / Q000378:metabolism; D015936:Complement C5a; D000242:Cyclic AMP / Q000096:biosynthesis / Q000494:pharmacology*; D015232:Dinoprostone; D004357:Drug Synergism; D006801:Humans; D007545:Isoproterenol / Q000494:pharmacology; D008223:Lymphoma / Q000473:pathology; D009000:Monocytes / Q000378:metabolism* / Q000473:pathology; D011458:Prostaglandins E / Q000494:pharmacology; D044087:Receptor, Anaphylatoxin C5a; D011951:Receptors, Complement / Q000187:drug effects / Q000378:metabolism
D003182:Complement C5; D011458:Prostaglandins E; D044087:Receptor, Anaphylatoxin C5a; D011951:Receptors, Complement; D005576:Colforsin; D003994:Bucladesine; D015936:Complement C5a; D000242:Cyclic AMP; D002117:Calcitriol; D015232:Dinoprostone; D007545:Isoproterenol; D015056:1-Methyl-3-isobutylxanthine